296) uated from the trial to the next stage of development. |
297) uture diabetes and cardiovascular disease development. |
298) clude community-based methods, and theory development. |
299) track shifts in the microbiota before CD development. |
300) ude children and parents in all stages of development. |
301) entary behaviour, to better inform policy development. |
302) t the effect of arsenic exposure in early development. |
303) in alcohol use disorder (AUD) medication development. |
304) essential for growth and brain growth and development. |
305) in clinical decision-making and guideline development. |
306) ontributing to these complications during development. |
307) , training and induction, and support and development. |
308) tasis during pregnancy is vital for fetal development. |
309) rized by low indicators of socioeconomic development. |
310) ohort study related to maternal and child development. |
311) pacts of emerging medical technologies on development. |
312) ated with low indicators of socioeconomic development. |
313) related to health equity and sustainable development. |
314) any biological processes including cancer development. |
315) nflammation predisposes colon cancer risk development. |
316) financial sustainability from their early development. |
317) n mitigation to support sustainable ocean development. |
318) f antioxidant defense and contrasted fish development. |
319) thropometric failure, and long-term child development. |
320) is a highly promising area for biomarker development. |
321) litate nonscreen-based habits and healthy development. |
322) sk factor strongly associated with asthma development. |
323) proliferation and preimplantation embryo development. |
324) ied as promising targets for such vaccine development. |
325) ciated with a heightened risk of leukemia development. |
326) ioritize research questions for knowledge development. |
327) ost important strategies for professional development. |
328) feasible mechanism for delivering faculty development. |
|